Prognosis in Patients with ST-Segment Elevation Myocardial Infarction Reperfused by PHDP: 1-Year MACEs Follow-Up

MLA

Jie Dou MS, et al. “Prognosis in Patients with ST-Segment Elevation Myocardial Infarction Reperfused by PHDP: 1-Year MACEs Follow-Up.” Clinical and Applied Thrombosis/Hemostasis, vol. 30, Aug. 2024. EBSCOhost, https://doi.org/10.1177/10760296241271394.

APA

Jie Dou MS, Jie Gao MS, Hui-Hui Yang MS, Ruoling Guo MS, Chao Jiang MM, Jiang Zhou MD, Xiaomei Yu MS, Jingtao Guo MD, Jinlong Zhang MD, & Donglei Luo MD. (2024). Prognosis in Patients with ST-Segment Elevation Myocardial Infarction Reperfused by PHDP: 1-Year MACEs Follow-Up. Clinical and Applied Thrombosis/Hemostasis, 30. https://doi.org/10.1177/10760296241271394

Chicago

Jie Dou MS, Jie Gao MS, Hui-Hui Yang MS, Ruoling Guo MS, Chao Jiang MM, Jiang Zhou MD, Xiaomei Yu MS, Jingtao Guo MD, Jinlong Zhang MD, and Donglei Luo MD. 2024. “Prognosis in Patients with ST-Segment Elevation Myocardial Infarction Reperfused by PHDP: 1-Year MACEs Follow-Up.” Clinical and Applied Thrombosis/Hemostasis 30 (August). doi:10.1177/10760296241271394.